Comparing the Impact of Tetrahydrocannabinol on 30‐Day Readmission Rates and Hospital Length of Stay in Patients With Depression
Mohammed E. Khedr, Yunjin Lee, Muhammed A. Mirza, Humberto Jimenez, Daniel Greer · 2026
Read Comparing the Impact of Tetrahydrocannabinol on 30‐Day Readmission Rates and Hospital Length of Stay in Patients With Depression by Mohammed E. Khedr, Yunjin Lee, Muhammed A. Mirza, Humberto Jimenez, Daniel Greer (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13601742.txt.
Description
Cannabis use is rising, and so are questions about what it does to people hospitalized for depression. Mohammed Khedr and co-authors reviewed 743 admissions for major depression at one academic hospital. About twenty-eight percent of patients tested positive for THC, the main psychoactive part of cannabis, on arrival.
The team compared the two groups on two outcomes: bouncing back into hospital within thirty days, and total length of stay. After adjusting for age, sex, other diagnoses, and other drug use, neither outcome differed by THC status. Older patients stayed longer; women stayed shorter. The authors caution that one center's records cannot settle the question. They call for larger studies of cannabis and psychiatric hospitalization.
Catalog record
| CREATOR | Mohammed E. Khedr, Yunjin Lee, Muhammed A. Mirza, Humberto Jimenez, Daniel Greer |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 22 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |